Dr. Jeffrey Carlson Performed the 1st Implantation of a Boston Scientific WaveWriter Alpha ImageReady™ MRI Compatible Spinal Cord Stimulator on the Peninsula

March 10. 2021

Dr. Jeffrey R. Carlson performed the outpatient surgery on a 62-year-old female at Coastal Virginia Surgery Center in Newport News, VA, on March 3, 2021.

The patient, who had previously experienced years of chronic pain in the lumbar spine, was able to walk, climb stairs, and be discharged 30 minutes after the procedure. In a follow-up call with the patient the next day, she expressed relief from her chronic pain.

This exciting technology is available for patients suffering from chronic pain where alternative therapies have not been successful. Interested patients may try the stimulator for one week with a temporary device implanted in OSC’s Interventional Pain Management Specialists’ office. Patients help direct the stimulation toward the pain area during implantation and may choose to feel a sensation, such as bubbling or feeling nothing at all.

“Spinal cord stimulators have made significant improvements in patients’ pain and are becoming more easily adjusted,” explained Dr. Jeffrey R. Carlson, Orthopaedic Surgeon and President and Managing Partner of Orthopaedic and Spine Center. “This new stimulator allows patients to remove the last real complaint patients have about the device, the inability to get an MRI after it is implanted. MRI aides in many diagnoses, so this innovation allows patients to have the necessary diagnostic tests for any condition requiring an MRI.”

OSC offers orthopedic, sports medicine, spine care, and a dedicated Interventional Pain Management Team, including two interventional pain management physicians and one pain psychologist who are dedicated to identifying and treating chronic pain disorders. Using minimally invasive treatment options and physical therapy, over 90 percent of our patients recover without surgery. The Team is rounded out with a pain psychologist to help patients live their best life despite chronic pain.

“We are thrilled to assist our patients in enjoying the lifestyle they want and deserve,” says Dr. Boyd W. Haynes III, President of Coastal Virginia Surgery Center. “Helping them to overcome chronic pain allows our patients to get back to the life they love. Procedures, such as this, can be safely performed in an outpatient surgical center setting allowing them to recover where they’d prefer, at home, with follow-up care.”

Coastal Virginia Surgery Center (CVSC) offers a wide range of outpatient surgery options, boasting seven orthopedic surgeons and two interventional pain management specialists. Surgery centers provide less exposure to serious infections and a high-level of care at a lower cost to both the patient and insurance company.

OSC physicians are accepting new patients, and CVSC is scheduling surgeries, both with additional precautions during the COVID-19 Pandemic.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”